CYTOMEGALOVIRAL INFECTION
Clinical trials for CYTOMEGALOVIRAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRAL INFECTION trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to shield transplant patients from deadly virus
⭐️ VACCINE ⭐️ OngoingThis phase II trial tests a vaccine designed to protect stem cell transplant recipients from cytomegalovirus (CMV), a common virus that can cause serious illness in people with weakened immune systems. The vaccine uses a modified, harmless virus to deliver three CMV proteins, tra…
Matched conditions: CYTOMEGALOVIRAL INFECTION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:32 UTC
-
Donor T-Cells take on stubborn CMV in transplant patients
Disease control OngoingThis phase 2 trial tests whether immune cells from donors who have been exposed to CMV can treat persistent CMV infections in patients who have had a stem cell transplant. The study includes 49 participants with CMV that hasn't improved with standard antiviral drugs. The cells ar…
Matched conditions: CYTOMEGALOVIRAL INFECTION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC